Merck & Co., Inc. (MRK) stock profile

Frequently asked questions

What does Merck & Co., Inc. (MRK) do?

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments: Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products for preventive pediatric, adolescent, and adult use. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, health management solutions and services, and digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed healthcare providers such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Where is MRK stock listed?

Merck & Co., Inc. trades under the ticker MRK on NYSE.

How can I research MRK's financials and filings?

Vantafin provides Merck & Co., Inc.'s income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the MRK profile.